SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPulsar Group Regulatory News (PULS)

Share Price Information for Pulsar Group (PULS)

Share Price is delayed by 15 minutes
Get Live Data
38.50    0.00 (0.00%)
Bid:
37.00
Ask:
40.00
Spread: 3.00 (8.108%)
Market Cap: £52.20m
PULS Live PriceLast checked at - London Stock Exchange

Intraday Pulsar Group Share Chart

Directors’ Dealings

7 Oct 2024 09:31

RNS Number : 1775H
Pulsar Group PLC
07 October 2024
Β 

7 October 2024

Β 

Pulsar Group plc ("the Company")

Directors' Dealings

Pulsar Group plc (AIM: PULS) received notification on 4 October 2024 from Kestrel Partners LLP ("Kestrel") that on 4 October 2024 Kestrel purchased, on behalf of its discretionary client accounts, an aggregate of 73,409 ordinary shares of 5 pence each ("Ordinary Shares") in the Company at an average price of Β£0.5757 per Ordinary Share.

Mr Royde is a partner of, and holds a beneficial interest in, Kestrel. Mr Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in the Company.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Royde is deemed to have a beneficial interest in) 18,085,921 Ordinary Shares in the Company, and other clients of Kestrel, in which Mr Royde has no beneficial interest hold 17,771,324 Ordinary Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 35,857,245 Ordinary Shares in the Company, which represents 28.08 per cent of the total voting rights in the Company.

Kestrel's interest in the Ordinary Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of Ordinary Shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

18,085,921

14.16%

Indirect

JIM Nominees Limited

2,385,250

1.87%

Indirect

Bank of New York Nominees Ltd

9,497,226

7.44%

Indirect

Northern Trust Company AVFC

5,888,848

4.61%

Β 

For further information contact:

Β 

Pulsar Group plc

Joanna Arnold (CEO)

Mark Fautley (CFO)

Β 020 3426 4070

Β 

Β 

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Corporate Finance:

Marc MalmoΒ /Β Fergus Sullivan

Β 

Corporate Broking

Sunila de Silva

020 7220 0500Β 

Β 

Β 

Β 

Β 

Β 

Β 

ANNEX

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Kestrel Partners LLP

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

PCA - Max Royde (non-executive director)

b)

Β 

Initial notification /Amendment

Initial

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Pulsar Group plc

b)

Β 

LEI

Β 

213800PPZ4ZM8OMHGT41

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Ordinary shares of 5 pence each ("Ordinary Shares")

Β 

Β 

ISIN: GB00BGQVB052

Β 

b)

Β 

Nature of the transaction

Β 

Β Purchase of Ordinary Shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

4 October 2024

Price(s)

Β 

Volume(s)

0.5890

38,409 shares

4 October 2024

Price(s)

Β 

Volume(s)

0.5611

35,000 shares

d)

Β 

Aggregated information

- Aggregated volume

- Price

Β 

Purchase total 73,409 shares at an average price of GBP 0.5757.

Β 

Β 

Β 

e)

Β 

Date of the transaction

4 October 2024

f)

Β 

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHVDLBBZBLLFBD
Date   Source Headline
28th May 20263:30 pmRNSResult of Annual General Meeting
7th May 202612:50 pmRNSPosting of Annual Report and Notice of AGM
1st May 20267:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2025
10th Apr 202611:35 amRNSDirector/PDMR Shareholding
7th Apr 20266:10 pmRNSDirector/PDMR Shareholding
27th Feb 20262:13 pmRNSDirectors' Dealings
24th Feb 20265:21 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSTrading Update
16th Jan 20267:00 amRNSHolding(s) in Company
16th Jan 20267:00 amRNSHolding(s) in Company
15th Jan 20264:32 pmRNSHolding(s) in Company
14th Jan 20264:44 pmRNSHolding(s) in Company
23rd Dec 20257:00 amRNSMajor Global Contract Win
23rd Dec 20257:00 amRNSMajor Global Contract Win
15th Dec 20254:05 pmRNSDirector/PDMR Shareholding
26th Sep 20255:42 pmRNSHolding(s) in Company
9th Sep 20256:23 pmRNSHolding(s) in Company
8th Sep 20257:00 amRNSHolding(s) in Company
14th Jul 20257:00 amRNSInterim Results
18th Jun 202510:25 amRNSHolding(s) in Company
29th May 20253:18 pmRNSResult of Annual General Meeting
14th May 20255:03 pmRNSTR - 1
13th May 202512:17 pmRNSTR-1
13th May 202512:17 pmRNSDirector Dealing
8th May 20257:00 amRNSResult of Placing, Related Parties & TVR
7th May 20254:39 pmRNSProposed Placing
1st May 20257:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2024
28th Apr 20257:00 amRNSStrategic Contract Expansion
10th Mar 20255:41 pmRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirectors' Dealings
24th Jan 20257:00 amRNSTrading Update
2nd Dec 20247:00 amRNSDisposal
7th Oct 20249:31 amRNSDirectors’ Dealings
30th Sep 20244:01 pmRNSHolding(s) in Company
30th Sep 20244:00 pmRNSDirectors’ Dealings
16th Sep 202410:06 amRNSChange of Registered Office Address
29th Aug 20247:00 amRNSBoard Changes
1st Aug 20247:00 amRNSBoard Change
15th Jul 20247:00 amRNSEstablishment of Long-Term Incentive Plan
8th Jul 20247:00 amRNSInterim Results
3rd Jul 20244:23 pmRNSResult of General Meeting
13th Jun 202412:10 pmRNSPosting of notice of GM
31st May 20241:23 pmRNSHolding(s) in Company
31st May 202412:45 pmRNSResult of Annual General Meeting
24th May 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 30 NOVEMBER 2023
9th May 20247:00 amRNSPosting of Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.